AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Deferred-Long-Term-Liabilities" stands at 2.12 Billion United States Dollars as of 06/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.81 percent compared to the value the year prior.
The 1 year change in percent is -5.81.
The 3 year change in percent is -55.61.
The 5 year change in percent is 27.19.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Deferred Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Deferred Long Term Liabilities | 486,508,953,600.00 |
![]() | Roche Holding AG - Deferred Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Deferred Long Term Liabilities | 280,205,508,085.11 |
![]() | Novartis AG - Deferred Long Term Liabilities | 255,096,620,580.91 |